Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in TAYSHA GENE THERAPIES INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 167,500 shares of TSHA (TAYSHA GENE THERAPIES INC), worth $921,250 as of 2025-Q4. This is a new position. TSHA represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$921,250
Current Shares
167,500
Total Value Change
$0
Total Shares Change
0
Other major holders of TSHA: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, BlackRock, Inc., MORGAN STANLEY, RTW INVESTMENTS, LP
New |
| 167,500 |
- |
| $921,250 |
| 0.0% |
| $5.66 |
35 |